Clinical Trial Update: Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing furosemide-digoxin versus polidocanol for cutaneous warts due to HPV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Warts
• Human Papillomavirus Infection

Drugs mentioned

• Furosemide-Digoxin (furosemide and digoxin)
• polidocanol (polidocanol)

Snippet

Sponsor: Benha University | Conditions: Cutaneous Warts, Human Papilloma Virus (HPV) | Phase 2 | Status: COMPLETED